FK Biotecnologia
Pioneering biomedical innovation with advanced biotech solutions since 1999.
Pioneering biomedical innovation with advanced biotech solutions since 1999.
FK Biotecnologia is a pioneering biomedical innovation company that has been advancing biotech solutions since 1999. Specializing in the production of biotech-based products, the company offers a wide range of offerings, including antibodies, equipment, labware, reagents, and solutions. Their services cover various aspects such as antibody development, lateral flow, and flow-through tests, Elisa tests, antibody purification and conjugation, and antibody isotyping.
In addition to these services, FK Biotecnologia provides therapeutic peptides for treating neurological disorders, oncology, obesity, and inflammatory diseases. The company also produces recombinant proteins, biosensors for detecting glucose, urea, and other enzymes, as well as bioinsecticides for applications in agriculture, public health, and households. Their diagnostic products include the detection of HCG, HIV, dengue, other infectious diseases, and early cancer detection, utilizing nanotechnology.
Headquartered in Porto Alegre, Brazil, FK Biotecnologia received a BRL625.00K Series A investment on 01 October 2000 from CRP Companhia de Participações. The company plays a significant role in the biotechnology, healthcare, and pharmaceutical industries, continuing to push the boundaries in the field of biomedical innovation.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | BRL625.00K | 1 | CRP Companhia de Participações | 01 Oct 2000 |
No recent news or press coverage available for FK Biotecnologia.
We care about your data, and we'd love to use cookies make your experience better.
